| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 30, 2023 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 6,181 | $555.32 | $3,432,417.36 | - | +8.0% | +71.6% | |
| Aug 30, 2023 | VRNO Verano Holdings Corp. | Weiss Darren Henry | President | Sell | 147,000 | $2.72 | $399,840.00 | -22.9% | - | - | |
| Aug 29, 2023 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 28,747 | $554.10 | $15,928,697.21 | - | +6.8% | +71.3% | |
| Aug 29, 2023 | ANIP Ani Pharmaceuticals Inc | Shanmugam Muthusamy59 | Head Of R&D, Coo-novitium Ops | Sell | 50,000 | $63.22 | $3,160,750.00 | -2.1% | -19.6% | -1.3% | |
| Aug 28, 2023 | AMPH Amphastar Pharmaceuticals, Inc. | Liawatidewi Yakob47 | EVP Corp Admin Center | Sell | 28,816 | $53.13 | $1,530,994.08 | -29.3% | +6.9% | -8.4% | |
| Aug 28, 2023 | NBIX Neurocrine Biosciences Inc | Delaet Ingrid67 | Chief Regulatory Officer | Sell | 1,431 | $107.52 | $153,861.12 | -19.4% | +5.7% | +42.7% | |
| Aug 28, 2023 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 37,660 | $7.38 | $277,770.00 | - | +6.8% | +72.3% | |
| Aug 25, 2023 | INIS International Isotopes Inc | Bagerdjian Shahe | President | Buy | 3,950 | $0.05 | $197.50 | - | - | - | |
| Aug 25, 2023 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 63,572 | $554.38 | $35,243,238.20 | - | +8.6% | +72.1% | |
| Aug 25, 2023 | CBSTF Cannabist Co Holdings Inc. | Channon Jesse | Chief Commercial Officer | Sell | 150,000 | $0.41 | $61,995.00 | -22.3% | - | - | |
| Aug 25, 2023 | SUPN Supernus Pharmaceuticals, Inc. | Martin Tami Tillotson54 | Sr. V.p., Regulatory Affairs | Sell | 5,135 | $31.59 | $162,214.65 | -5.7% | -11.3% | +11.4% | |
| Aug 25, 2023 | AKBA Akebia Therapeutics, Inc. | Burke Steven Keith61 | SVP, Chief Medical Officer | Sell | 27,000 | $1.15 | $31,050.00 | -3.9% | -13.0% | +33.0% | |
| Aug 25, 2023 | TLPH Talphera, Inc. | Palmer Pamela P | Chief Medical Officer | Sell | 16,956 | $1.13 | $19,235.72 | -19.7% | -36.7% | -17.4% | |
| Aug 24, 2023 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 20,992 | $554.74 | $11,645,029.20 | - | +8.6% | +73.9% | |
| Aug 24, 2023 | VRNO Verano Holdings Corp. | Archos George Peter | Chief Executive Officer | Sell | 4,660 | $2.59 | $12,069.40 | -0.7% | - | - | |
| Aug 24, 2023 | BMY Bristol Myers Squibb Co | Powell Ann64 | EVP, Chief Human Resources | Sell | 17,986 | $61.25 | $1,101,642.50 | -39.2% | -19.4% | -21.5% | |
| Aug 24, 2023 | VRNO Verano Holdings Corp. | Kalesnik Laura Marie | See Remarks | Sell | 6,084 | $2.59 | $15,757.56 | -11.2% | - | - | |
| Aug 24, 2023 | VRNO Verano Holdings Corp. | Spreckman David | Chief Marketing Officer | Sell | 215 | $2.59 | $556.85 | -0.3% | - | - | |
| Aug 24, 2023 | VRNO Verano Holdings Corp. | Miles Aaron Nathaniel | Chief Investment Officer | Sell | 988 | $2.59 | $2,558.92 | -1.2% | - | - | |
| Aug 24, 2023 | VRNO Verano Holdings Corp. | Weiss Darren Henry | President | Sell | 8,242 | $2.59 | $21,346.78 | -1.3% | - | - | |
| Aug 24, 2023 | DVAX Dynavax Technologies Corp | Janssen Robert71 | SVP And CMO | Sell | 600 | $15.02 | $9,012.00 | -1.2% | -9.2% | -22.6% | |
| Aug 24, 2023 | VRNO Verano Holdings Corp. | Tarapchak Richard C | Corporate Controller | Sell | 11,630 | $2.59 | $30,121.70 | -26.9% | - | - | |
| Aug 23, 2023 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 1,307 | $555.69 | $726,284.48 | - | +7.1% | +72.4% | |
| Aug 23, 2023 | DVAX Dynavax Technologies Corp | Janssen Robert71 | SVP And CMO | Sell | 34,857 | $15.01 | $523,203.57 | -41.1% | -9.6% | -24.7% | |
| Aug 23, 2023 | ANIP Ani Pharmaceuticals Inc | Marken James G.47 | SVP Ops &Prod Dev | Sell | 3,932 | $63.00 | $247,716.00 | -2.9% | -18.8% | -5.1% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.